<DOC>
	<DOCNO>NCT00006286</DOCNO>
	<brief_summary>TADS design compare effectiveness establish treatment teenager suffer major depressive disorder ( MDD ) . The treatment : psychotherapy ( `` talk therapy '' ) ; medication ; combination psychotherapy medication . Altogether , 432 teenager ( male female ) age 12 17 , take part study 12 site United States . The TADS design provide answer follow question : What long-term effectiveness medication treatment teenager major depression ? What long-term effectiveness specific psychotherapy ( `` talk therapy ) treatment teenager major depression ? How medication treatment compare psychotherapy term effectiveness , tolerability teenager family acceptance ? And , What cost-effectiveness medication , psychotherapy combine treatment ? The medication use study call fluoxetine . Fluoxetine also know Prozac . Research show medication like Prozac help depression young person . Fluoxetine approve FDA use treatment child adolescent ( age 7 17 year ) depression . The psychotherapy `` talk therapy '' use study call Cognitive Behavioral Therapy ( CBT ) . CBT talk therapy teach teenager family member ( e.g. , parent ) new skill cope good depression . Specific topic include education depression cause depression , set goal , monitor mood , increase pleasant activity , social problem-solving , correct negative thinking , negotiation , compromise assertiveness . CBT session may also help resolve disagreement affect family .</brief_summary>
	<brief_title>Treatment Adolescents With Depression Study ( TADS )</brief_title>
	<detailed_description>TADS randomize controlled clinical trial compare effectiveness establish treatment -- -cognitive-behavioral psychotherapy , medication management , combination -- -for adolescent suffer major depressive disorder ( MDD ) . The experimental design consist three treatment stage follow-up phase . Stage I ( 12 week ) four-group randomize comparison four treatment : antidepressant medication alone ( Fluoxetine ) ; psychotherapy alone ( CBT ) ; combination medication psychotherapy ( Comb ) ; placebo control medication condition ( Pbo ) . Stage II ( six week ) treatment consolidation phase ask whether long treatment responder higher intensity treatment partial responder Stage I treatment would helpful . Non-responders end Stage I refer open community treatment , ethical practical reason case non-responders Placebo , open treatment choice one three active study treatment administer study team . Responders end Stage I advance 6 week maintenance treatment assign arm . Partial responder CBT receive additional 6 week CBT assign arm ; partial responder Fluoxetine may receive high dose six week . Partial responder Comb treatment receive additional 6 week CBT may receive high dose medication six week . Stage III ( 18 week ) treatment maintenance phase teenager continue respond well . Treatment continue progress monitor . Stage IV ( one year ) assessment-only follow-up phase help u understand long-term benefit treatment . The recruitment strategy design enter treatment volunteer clinical sample 432 teenager , male female , age 12 17 , ten site . A multiple gating procedure use patient screen , assess study eligibility , eligible , consented randomization one four treatment group . Patients select without regard race , gender , ethnicity expect sample match patient see general clinical practice . Patients recruit multiple source include : mental health identify child , i.e. , child already come clinic ; primary care identify child ( pediatric family physician ) ; teacher school identify child ( i.e. , school refers parent primary caretaker ) ; family self-refer .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<criteria>Primary diagnosis DSMIV Major Depressive Disorder , pervasive stable ; Children 's Depression Rating ScaleR total score least 45 ; Ages 1217 inclusive ; Grade school : 612 ; FullScale IQ least 80 ; Medicationfree start study ; Outpatient ; Parent ( family member ) involvement Bipolar disorder ; Severe Conduct Disorder ; Substance Use/Abuse/Dependence ; Pervasive Developmental Disorders ; Thought Disorder ; Suicidality homicidality ; Concurrent treatment psychotropic drug ( stable stimulant ADHD permit ) psychotherapy outside study ; Two previous fail SSRI trial fail trial CBT depression ; Intolerance fluoxetine ; NonEnglish speaking patient ; Pregnancy breastfeeding ; No phone home ; Lack parent family member ) involvement .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2005</verification_date>
	<keyword>Depression</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Fluoxetine</keyword>
	<keyword>Prozac</keyword>
	<keyword>SSRI</keyword>
	<keyword>Psychotherapy</keyword>
	<keyword>CBT</keyword>
	<keyword>Teenagers</keyword>
	<keyword>Adolescents</keyword>
	<keyword>Teens</keyword>
</DOC>